Vivo Opportunity Fund Holdings, L.P. 13D and 13G filings for Pasithea Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-05 4:00 pm Purchase | 2025-12-01 | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | Vivo Opportunity Fund Holdings, L.P. | 17,560,467 9.990% | 17,560,467 (New Position) | Filing |